VKTX — Viking Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-General Motors, Caterpillar, Medtronic
Factbox: The race to launch first weight-loss pill
U.S. STOCKS ON THE MOVE-Intel, Palo Alto, Home Depot
Brief: Viking Therapeutics Announces Positive Top-Line Results From Phase 2 Venture-Oral Dosing Trial Of Vk2735 Tablet Formulation In Patients With Obesity
Viking Therapeutics' oral pill helps up to 12.2% weight-loss in mid-stage study (updated)
Viking Therapeutics' oral obesity drug meets mid-stage study goal, shares fall
Viking Therapeutics' oral weight-loss pill meets expectations in mid-stage study
Factbox: Drugmakers racing to launch the first weight-loss pill
Lilly falls after oral weight-loss drug data fails to impress
Lilly falls after oral weight-loss drug data fails to impress
Eli Lilly falls after late-stage data for oral weight-loss drug
GSK revenue hole raises chances of risky M&A move
Street View: Analysts eye Viking's oral obesity drug data in second half
Viking Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Viking Therapeutics Q2 net loss widens, misses expectations
U.S. STOCKS ON THE MOVE-Coinbase, Rubrik, AeroVironment
U.S. STOCKS ON THE MOVE-Coinbase, Rubrik, AeroVironment
U.S. STOCKS ON THE MOVE-Array Technologies, Viking Therapeutics, Winnebago
Viking Therapeutics rises after it starts late-stage study of obesity drug